Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew revision entry added to the record history, updating the page to Revision: v3.6.5. This replaces the previous Revision: v3.6.4 and reflects an updated version of the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new site revision tag, Revision: v3.6.4, has been added to the record history to reflect a minor platform update. The previous revision, v3.6.3, is removed from the current history entry.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history and the previous entry v3.6.2 was removed, reflecting an update to the study record's version history.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page history now includes a newer revision tag, v3.6.2, and the older tag, v3.6.0, is removed, indicating an update to the study record's revision history.SummaryDifference0.1%

- Check66 days agoChange DetectedRecord history now indicates that the study is no longer looking for participants, signaling that enrollment has ceased. The entry also updates the record version to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page shows a new software revision label, updating from v3.5.4 to v3.5.5. This indicates a platform-level release for the history view rather than changes to the study record itself.SummaryDifference0.1%

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.